Stay updated on DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page
- Check7 days agoChange DetectedBranding elements referencing Mayo Clinic (the Mayo Clinic web site, Mayo Clinic, and the 'Helpful Links Provided by Mayo Clinic' blocks) were removed from the page.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page’s footer revision/version indicator was incremented from **v3.5.2** to **v3.5.3**, reflecting a site/record interface update rather than a change to the clinical trial details.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No substantive content changes are visible.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded a new site revision note: v3.4.2. The notices about government funding lapse and the older revision v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC Therapy After Cryosurgery With Pembrolizumab in Melanoma Clinical Trial page.